NCT06315777View on ClinicalTrials.gov

GREM1, HAS2 and PTGS2 Gene Expression Following the in Vitro Maturation (IVM)

NARecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 1, 2021

Primary Completion Date

July 1, 2024

Study Completion Date

July 31, 2024

Conditions
Increased Oocyte Deathin Vitro MaturationGREM1 Gene MutationCumulus Cell
Interventions
GENETIC

cumulus cell oocytes complex (COC) among women with poor ovarian reserve

level of expression of Gremlin-1 (GREM1), Hyaluronic acid synthetase-2 (HAS2), and Prostaglandin-endoperoxide synthase-2 (PTGS2) in cumulus cell oocytes complex (COC) among women with poor ovarian reserve were analyzed

Trial Locations (1)

56000

RECRUITING

Advanced Reproductive Centre, Kuala Lumpur

All Listed Sponsors
lead

National University of Malaysia

OTHER